MB "IVB Pharma Consulting" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 223,245 |
| 212,614 |
| 100,459 |
| 95,927 |
| 91,359 |
| 75.62 |
| 42.97 |
| 183,659 |
| 16,590 |
| 0 |
| 200,249 |
| 2024 |
|---|
| 256,854 |
| 256,854 |
| 99,759 |
| 95,478 |
| 95,478 |
| 80.27 |
| 37.17 |
| 241,298 |
| 12,122 |
| 0 |
| 253,420 |
| 2025 |
|---|
| 282,337 |
| 282,337 |
| 139,853 |
| 132,251 |
| 132,251 |
| 79.50 |
| 46.84 |
| 299,306 |
| 12,876 |
| 0 |
| 312,182 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 282,337 |
| 282,337 |
| 139,853 |
| 132,251 |
| 132,251 |
| 79.50 |
| 46.84 |
| 299,306 |
| 12,876 |
| 0 |
| 312,182 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
282,337 €10 % *
Sales per employee (€)
282,337 €10 % *
Profit before tax (€)
139,853 €40 % *
Net Profit (€)
132,251 €39 % *
Profit per employee (€)
132,251 €39 % *
Total profitability (%)
79.50 %-0.96 % *
Net profitability (%)
46.84 %26.02 % *
Equity (€)
299,306 €24 % *
Amounts Payable And Liabilities (€)
12,876 €6 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
312,182 €23 % *
